Kovács, K.; Nagypál, P.; Vásárhelyi, B.; Dezsőfi-Gottl, A.; Béres, N.; Miheller, P.; Iliás, Á.; Balogh, A.; Prehoda, B.; Tóbi, L.;
et al. Interaction of Clinical Factors Modestly Predict Anti-TNF-Alpha Antibody Formation in a Real-World Cohort of Inflammatory Bowel Disease Patients. Biomedicines 2025, 13, 2622.
https://doi.org/10.3390/biomedicines13112622
AMA Style
Kovács K, Nagypál P, Vásárhelyi B, Dezsőfi-Gottl A, Béres N, Miheller P, Iliás Á, Balogh A, Prehoda B, Tóbi L,
et al. Interaction of Clinical Factors Modestly Predict Anti-TNF-Alpha Antibody Formation in a Real-World Cohort of Inflammatory Bowel Disease Patients. Biomedicines. 2025; 13(11):2622.
https://doi.org/10.3390/biomedicines13112622
Chicago/Turabian Style
Kovács, Krisztián, Petra Nagypál, Barna Vásárhelyi, Antal Dezsőfi-Gottl, Nóra Béres, Pál Miheller, Ákos Iliás, Anna Balogh, Bence Prehoda, Luca Tóbi,
and et al. 2025. "Interaction of Clinical Factors Modestly Predict Anti-TNF-Alpha Antibody Formation in a Real-World Cohort of Inflammatory Bowel Disease Patients" Biomedicines 13, no. 11: 2622.
https://doi.org/10.3390/biomedicines13112622
APA Style
Kovács, K., Nagypál, P., Vásárhelyi, B., Dezsőfi-Gottl, A., Béres, N., Miheller, P., Iliás, Á., Balogh, A., Prehoda, B., Tóbi, L., Szabó, A., & Cseh, Á.
(2025). Interaction of Clinical Factors Modestly Predict Anti-TNF-Alpha Antibody Formation in a Real-World Cohort of Inflammatory Bowel Disease Patients. Biomedicines, 13(11), 2622.
https://doi.org/10.3390/biomedicines13112622